Status:
COMPLETED
Clinical Trial of Oral Midazolam in Pediatric Endoscopy
Lead Sponsor:
Tabriz University
Conditions:
Endoscopy
Eligibility:
All Genders
3-17 years
Phase:
PHASE4
Brief Summary
The objective of our study was to compare the safety and efficacy of oral midazolam during pediatric endoscopy.
Detailed Description
Although gastrointestinal endoscopy is widely accepted as fundamental to the diagnosis and treatment of digestive disorders in children, considerable controversy and practice differences persist with ...
Eligibility Criteria
Inclusion
- All of patients scheduled for endoscopy participated in the study.
Exclusion
- Exclusion criteria were as follows:
- Children younger than 3 years;
- Children with significant neurological disability;
- Children with a history of allergies to benzodiazepines, or to their components;
- Children with metabolic, cardiac or renal disease; children with previous - Complications to IV sedation;
- Children with respiratory distress
- Age under 1 mo and bigger than 17y
- History of erythromycin used in 4 week ago
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00636428
Start Date
March 1 2007
End Date
March 1 2008
Last Update
April 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Liver &Gastrointestinal Research center of tabriz medical university
Tabriz, East Azarbijan, Iran, 51664